Group 1 - Baili Tianheng (688506.SH) released its semi-annual report for 2025 on August 20, 2025, indicating that as of August 19, 2025, 113 institutional investors disclosed holdings in Baili Tianheng A-shares, totaling 65.5261 million shares, which accounts for 16.34% of the total share capital [1] - The top ten institutional investors include OAP III (HK) Limited, China Merchants Bank Co., Ltd. - Huaxia SSE STAR 50 ETF, and others, with a combined holding ratio of 13.07%, reflecting an increase of 0.40 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 15 funds increased their holdings compared to the previous period, with notable funds including Yongying Medical Innovation Mixed Fund A and China Europe Medical Health Mixed Fund A, representing an increase ratio of 0.33% [2] - Conversely, 36 public funds reduced their holdings, including Huatai-PB Daxin Mixed Fund A and Ping An Medical Health Mixed Fund A, with a decrease ratio of 0.97% [2] - Additionally, 55 new public funds disclosed their holdings this period, including Huatai-PB Innovative Medical Mixed Fund A and CITIC Jian Investment Medical Reform A [2]
机构风向标 | 百利天恒(688506)2025年二季度已披露持股减少机构超30家